PurposeThis paper seeks to define a coherent management preference function for determining the conditions when the market can be effectively used in the management of spectrum based on abduction and volitional pragmatism.Design/methodology/approachVolitional pragmatism based on the logic of abduction is used to provide an explanation for real world empirical observation of few spectrum trades in the UK. This is generalized for application with wider context of European frequency management.FindingsThere has been a considerable regulatory effort directed toward spectrum trading in the EU. The UK experience with trading is clearly not what was expected. It was suggested that this is a result of an analytical approach based on deductive validationism subject to ceteris paribus assumptions. This approach does have merit but its application is over extended. This is due in large part institutional under specification of what constitutes the market and the nature of the transaction taking place.Research limitations/implicationsThe emphasis is in this paper is on the explanation of real world facts rather than normative prescription based on deductive validationism. Such an approach though fallible (all facts cannot be taken into account) is no less valuable in the process of regulatory decision making than deductive validationism.Practical implicationsThis paper provides a more coherent explanation of spectrum development and the spectrum management reform process.Originality/valueA set of conditions are provided for determining when the market can be used in the management of spectrum. This makes explicit the intended operation of the market as well as its limitations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.